おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Ingenium Pharmaceuticals AG
company
About
Ingenium Pharmaceuticals AG is discovers and develops molecules for the treatment of neuronal and autoimmune diseases.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- €50M
- Industries
- Biotechnology
- Founded date
- Jan 1, 1997
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Ingenium Pharmaceuticals AG is discovers and develops molecules for the treatment of neuronal and autoimmune diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€50M
Ingenium Pharmaceuticals AG has raised a total of
€50M
in funding over 2 rounds. Their latest funding was raised on
Oct 1, 2000 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 1, 2000 | Series B | €50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Ingenium Pharmaceuticals AG is funded by 1 investors.
Bayern Kapital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Bayern Kapital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
